Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial
Titel:
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial
Auteur:
Winston, Alan Post, Frank A DeJesus, Edwin Podzamczer, Daniel Di Perri, Giovanni Estrada, Vicente Raffi, François Ruane, Peter Peyrani, Paula Crofoot, Gordon Mallon, Patrick W G Castelli, Francesco Yan, Mingjin Cox, Stephanie Das, Moupali Cheng, Andrew Rhee, Martin S